FI119622B - 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin hoitoon tarkoitettujen farmaseuttisten valmisteiden valmistukseen - Google Patents

2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin hoitoon tarkoitettujen farmaseuttisten valmisteiden valmistukseen Download PDF

Info

Publication number
FI119622B
FI119622B FI982689A FI982689A FI119622B FI 119622 B FI119622 B FI 119622B FI 982689 A FI982689 A FI 982689A FI 982689 A FI982689 A FI 982689A FI 119622 B FI119622 B FI 119622B
Authority
FI
Finland
Prior art keywords
compound
alzheimer
disease
cells
phenyl
Prior art date
Application number
FI982689A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI982689A0 (fi
FI982689A (fi
Inventor
Kazuhiro Abeyama
Hiroyuki Masayasu
Ikuo Maruyama
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of FI982689A0 publication Critical patent/FI982689A0/fi
Publication of FI982689A publication Critical patent/FI982689A/fi
Application granted granted Critical
Publication of FI119622B publication Critical patent/FI119622B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI982689A 1996-08-27 1998-12-11 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin hoitoon tarkoitettujen farmaseuttisten valmisteiden valmistukseen FI119622B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27
JP22551296 1996-08-27
DE9700701 1997-04-07
PCT/DE1997/000701 WO1998008511A1 (de) 1996-08-27 1997-04-07 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit

Publications (3)

Publication Number Publication Date
FI982689A0 FI982689A0 (fi) 1998-12-11
FI982689A FI982689A (fi) 1998-12-11
FI119622B true FI119622B (fi) 2009-01-30

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
FI982689A FI119622B (fi) 1996-08-27 1998-12-11 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin hoitoon tarkoitettujen farmaseuttisten valmisteiden valmistukseen

Country Status (29)

Country Link
US (1) US5948800A (sl)
EP (1) EP0826370B1 (sl)
KR (1) KR20000035859A (sl)
CN (1) CN1112922C (sl)
AT (1) ATE219361T1 (sl)
AU (2) AU3866997A (sl)
BR (1) BR9711259A (sl)
CA (1) CA2213794C (sl)
CZ (1) CZ295364B6 (sl)
DE (2) DE59707550D1 (sl)
DK (1) DK0826370T3 (sl)
EE (1) EE03953B1 (sl)
ES (1) ES2177849T3 (sl)
FI (1) FI119622B (sl)
HK (1) HK1020317A1 (sl)
HU (1) HU225264B1 (sl)
IL (1) IL127113A (sl)
LT (1) LT4602B (sl)
LV (1) LV12251B (sl)
NO (1) NO312812B1 (sl)
NZ (1) NZ332292A (sl)
PL (1) PL188481B1 (sl)
PT (1) PT826370E (sl)
SI (1) SI9720060B (sl)
TR (1) TR199700858A2 (sl)
TW (1) TW501925B (sl)
UA (1) UA59367C2 (sl)
WO (2) WO1998008511A1 (sl)
ZA (1) ZA977644B (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0729756T3 (da) * 1993-10-27 2000-06-05 Daiichi Seiyaku Co Granulært farmaceutisk præparat
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010153A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
HK1020317A1 (en) 2000-04-14
UA59367C2 (uk) 2003-09-15
CN1112922C (zh) 2003-07-02
HUP9903213A3 (en) 2000-12-28
AU3529897A (en) 1998-03-05
FI982689A0 (fi) 1998-12-11
NO973912L (no) 1998-03-02
SI9720060B (en) 2001-12-31
ZA977644B (en) 1999-02-26
TW501925B (en) 2002-09-11
LV12251B (lv) 1999-08-20
HUP9903213A1 (en) 2000-07-28
KR20000035859A (ko) 2000-06-26
FI982689A (fi) 1998-12-11
PT826370E (pt) 2002-10-31
EE9900007A (et) 1999-06-15
ATE219361T1 (de) 2002-07-15
PL321796A1 (en) 1998-03-02
BR9711259A (pt) 1999-08-17
US5948800A (en) 1999-09-07
HU225264B1 (en) 2006-08-28
LT4602B (lt) 2000-01-25
CZ295364B6 (cs) 2005-07-13
TR199700858A2 (xx) 1998-03-21
PL188481B1 (pl) 2005-02-28
NO973912D0 (no) 1997-08-26
DE59707550D1 (de) 2002-07-25
SI9720060A (sl) 1999-06-30
AU3866997A (en) 1998-03-19
IL127113A0 (en) 1999-09-22
CZ31799A3 (cs) 1999-11-17
WO1998008831A1 (fr) 1998-03-05
IL127113A (en) 2003-07-06
AU725534B2 (en) 2000-10-12
EP0826370A1 (de) 1998-03-04
CA2213794A1 (en) 1998-02-27
EP0826370B1 (de) 2002-06-19
CA2213794C (en) 2006-10-03
NZ332292A (en) 2001-07-27
CN1223580A (zh) 1999-07-21
WO1998008511A1 (de) 1998-03-05
ES2177849T3 (es) 2002-12-16
LT99016A (en) 1999-10-25
LV12251A (lv) 1999-04-20
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
NO312812B1 (no) 2002-07-08
EE03953B1 (et) 2003-02-17

Similar Documents

Publication Publication Date Title
FI119622B (fi) 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin hoitoon tarkoitettujen farmaseuttisten valmisteiden valmistukseen
US6261606B1 (en) Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions
EP2324838A1 (en) Compositions Comprising Dimethyl Sulfoxide (DMSO)
EP0914124B1 (fr) COMPOSITION PHARMACEUTIQUE ANTITHROMBOTIQUE ET ANTIATHEROGENE COMPRENANT UN DERIVE DE THIENOPYRIDINE ET UN INHIBITEUR DE LA HMG-CoA-REDUCTASE
US20080300253A1 (en) Treatment of inflammatory disorders with praziquantel
US6420429B1 (en) Brain targeted low molecular weight hydrophobic antioxidant compounds
JP2002542191A (ja) グルタチオンの吸収を増しかつその効果を補強するのに有用な、カルニチンおよびグルタチオン含有組成物
KR20100077552A (ko) 벤조아릴우레이도 화합물, 및 이를 함유하는 퇴행성 뇌질환예방 또는 치료용 조성물
US6159986A (en) Compounds and therapy for resisting memory loss in humans
CA2494503C (en) Treatment of multiple sclerosis with brain targeted anti oxidant compounds
KR20060107825A (ko) 간 기능 보호 작용 조성물
KR100467471B1 (ko) 신경세포 보호활성을 갖는 상황버섯 균사체 추출물 및이를 함유하는 퇴행성 뇌신경계 질환의 예방 및 치료제
Vallinas et al. Nitric oxide mediates the antihypertensive and vascular relaxing effects of a soluble cocoa fiber product in spontaneously hypertensive rats
Zigmond et al. Studies on the interaction between catecholamines and tyrosine aminotransferase in brain
CA1140858A (en) Process and composition for decreasing blood serum prolactin levels
KR101775267B1 (ko) 홍삼오일을 유효성분으로 포함하는 퇴행성 신경질환 예방 또는 치료용 조성물
US3772440A (en) Method for the treatment of parkinsonism and depression
WO2002098405A1 (fr) Inhibiteurs de fibrose du foie
CN115724786A (zh) 酰胺烷二硫邻苯二甲酰亚胺类化合物、其制备方法和用途
KR101217263B1 (ko) 시스테인 또는 메타이오닌을 포함하는 갭 결합을 통한세포간 정보전달 억제 예방 및 치료용 조성물
CN115724824A (zh) 3-(酰胺烷硫基)苯酞类化合物、其制备方法和用途
KR20170076264A (ko) 코릴라진을 유효성분으로 포함하는 퇴행성 신경질환 예방 또는 치료용 조성물
JP2005263723A (ja) β−アミロイド毒性緩和剤。
WO1997028184A1 (en) Method of treating beta-amyloid peptide associated conditions using trh
WO2009079739A1 (en) The use of creatine pyroglutamicacid salt to facilitate increased neural health

Legal Events

Date Code Title Description
MM Patent lapsed